β-Endorphin and the Immune System - Possible Role in Autoimmune Diseases

References

• Williams textbook of endocrinology8th edition, J D. Wilson, D W. Foster, C J. Heijnen, A. Kavelaars, R E. Ballieux, 1991; 119: 41–63, β-endorphin: Cytokine and Neuropeptide. Immunologkal Reviews
   Google Scholar
• Apte R N., Durum S K., Oppenheim J J. Opioids modulate interleukin-1 production and secretion by bone-marrow macrophages. Immunology Letters 1990; 24: 141–148
   PubMed Web of Science ®Google Scholar
• Gillmore W., Weiner L P. The opioid specificity of beta-endorphin enhancement of murine lymphocyte proliferation. Immunopharmacology 1989; 17: 19–30
   Google Scholar
• Carr D J.J. The Role of Endogenous Opioids and Their Receptors in the Immune System. Proceedings of the Society for Experimental Biology and Medicine. 1991, 710–720
   Google Scholar
• Zagon I S., Gibo D M., McLaughlin P J. Adult and developing human cerebella exhibit different profiles of opioid binding sites. Brain Research 1990; 523: 62–68
   PubMed Web of Science ®Google Scholar
• Sonders M S., Keana J F.W., Weber E. Phencyclidine and psychotomimetic sigma opiates: recent insights into their biochemical and physiological sites of action. Trends in ncurosciences 1988; 11: 37–40
   Google Scholar
• Zagon I S., Gibo D M., McLaughlin P J. Expression of Zeta (ζ), a Growth-Related Opioid Receptor, in Metastatic Adenocarcinoma of the Human Cerebellum. Journal of the National Cancer Institute 1990; 82: 325–327
   Google Scholar
• Heagy W., Laurance M., Cohen E., Finberg R. Neuro-hormones regulate t cell function. Journal of Experimental Medicine 1990; 171: 1625–1633
   Google Scholar
• Olson G A., Olson R D., Kastin AJ. Endogenous opiates. Peptides 1990; 1991: 121407–1432
   Google Scholar
• Young E A., Houghten R A., Akil H. Degradation of [3H]β-endorphin in rat plasma is increased with chronic stress. European Journal of Pharmacology 1989; 167: 229–236
   Google Scholar
• Farrell P A., Kjaer M., Bacj F W., Galbo H. Beta-endorphin and adrenocorticotropin response to supramaxi-mal treadmill exercise in trained and untrained males. Acta. Phvsiol. Scand 1987; 130: 619–625
   PubMedGoogle Scholar
• Farrar W L., Hill J M., Harel-Bellan A., Vinocour M. The Immune Logical Brain. Immunological Reviews 1987; 100: 361–378
   PubMed Web of Science ®Google Scholar
• Lapchak P A., Araujo D M. Interleukin-2 regulates monoamine and opioid release from the hypothalamus. Neuroreport 1993; 4: 303–306
   Google Scholar
• Levine J D., Collier D H., Basbaum A L. Hypothesis: The nervous system may contribute to the pathophysiology of rheumatoid arthritis. J. Pheumatol 1985; 12: 406–411
   PubMed Web of Science ®Google Scholar
• Sibinga N E.S., Goldstein A. Opioid peptides and opioid receptors in cells of the immune system. Ann. Rev. Immunol 1988; 6: 219–249
   PubMed Web of Science ®Google Scholar
• Famaey J P., Appelboom T., Wybran J. The nervous system and the pathophysiology of rheumatoid arthritis: The role of neurotensin and opioid peptides. J. Rheumatol 1986; 13: 651–652
   Google Scholar
• Madden K S., Felten D L. Experimental basis for neural-immune interactions. Physiological Reviews 1995; 75: 77–106
   PubMed Web of Science ®Google Scholar
• Gillmore W., Weiner L P. β-endorphin enhances interleukin-2 (IL-2) production in murine lymphocytes. Journal of Neuroimmunology 1988; 18: 125–138
   Google Scholar
• Bessler H., Sztein M B., Serrate S A. β-endorphin modulation of IL-1-induced IL-2 production. Immunopharmacology 1990; 19: 5–14
   PubMedGoogle Scholar
• Garcia I., Perez-Castillo A., Moreno J., Alemany S. β-endorphin Inhibits Interleukin-2 Release and Expression of Interleukin-2 Receptors in Concanavalin A-Stimulated Splenic Lymphocytes. Lymphokine and Cytokine Research 1992; 11: 339–345
   PubMedGoogle Scholar
• Hemmick L M., Bidlack J M. β-endorphin stimulates rat T lymphocyte proliferation. Journal of Neuroimmunology 1990; 29: 239–248
   PubMed Web of Science ®Google Scholar
• McCain H W., Lamster I B., Bozzone J M., Grebic J T. β-endorphin modulates human immune activity via non-opiate receptor mechanisms. Life Sciences 1982; 31: 1619–1624
   PubMed Web of Science ®Google Scholar
• Fontana L., Fattorossi A., D'Amelio R., Migliorati A., Perricone R. Modulation of human Concanavalin A-induced lymphocyte proliferative response by physiological concentrations of β-endorphin. Immunopharmacology 1987; 13: 111–115
   PubMedGoogle Scholar
• Gilman S C., Schwartz J M., Milner R J., Bloom F E., Feldman J D. β-endorphin enhances lymphocyte proliferative responses. Proceedings of the National Academy of Sciences of USA. 1982, 4226–4230
   Google Scholar
• Heijnen C J., Zijlstra J., Kavelaars A., Croiset G., Bal-Lieux R E. Modulation of the Immune Response by POMC-Derived Peptides. Brain, Behavior, and Immunity 1987; 1: 284–291
   PubMedGoogle Scholar
• Millar D B., Hough C J., Mazorow D L., Gootenberg J E. β-endorphin's Modulation of Lymphocyte Proliferation is Dose, Donor, and Time Dependent. Brain, Behavior, and Immunity 1990; 4: 232–242
   PubMed Web of Science ®Google Scholar
• van dan Bergh P., Rozing J., Nagelkerken L. Identification of Two Moities of Beta-endorphin With Opposing Effects on Rat T-cell Proliferation. Immunology 1993; 79: 18–23
   Google Scholar
• Song Ye., Applegren R R., Davis J M., Cheung H T. Modulation of lymphocyte motility by β-endorphin and met-enkephalin. Immunopharmacology 1989; 17: 81–89
   Google Scholar
• Hazum E., Chang K-J., Cuatrecasas P. Specific Nonopi-ate Receptors for β-endorphin. Science 1979; 205: 1033–1035
   PubMed Web of Science ®Google Scholar
• Hemmick L M., Bidlack J M. β-endorphin modulation of mitogen-stimulated calcium uptake by rat thymocytes. Life Sciences 1987; 41: 1971–198
   Google Scholar
• Hough C J., Halperin J I., Mazorow D L., Yeandle S J., Millar D B. β-Endorphin modulates T-cell intracellular calcium flux and c-myc expression via a potassium channel. Journal of Neuroimmunology 1990; 27: 163–171
   PubMedGoogle Scholar
• Giedroc D P., Puett D., Ling N., Staros J V. Demonstration by Covalent Cross linking of a Specific Interaction between β-Endorphin and Calmodulin. The Journal of Biological Chemistry 1983; 258: 16–19
   PubMed Web of Science ®Google Scholar
• Kavelaars A., Ballieux R E., Heijnen C J. Differential Effects of β-Endorphin on CAMP Levels in Human Peripheral Blood Mononuclear Cells. Brain, Behavior, and Immunity 1990; 4: 171–179
   PubMed Web of Science ®Google Scholar
• Kavelaars A., Eggen B J.L., De Graan P N.E., Gispen W H., Heijnen C J. The phosphorylation of the CD3 γ chain of T lymphocytes is modulated by β-endorphin. European Journal of Immunology 1990; 20: 943–945
   Google Scholar
• Chiapelli F., Nguyen L., Bullington R., Fahey J L. β-Endorphin Blunts Phosphatidylinositol Formation during in vitro Activation of Isolated Human Lymphocytes: Preliminary Report. Brain, Behavior, and Immunity 1992; 6: 1–10
   Google Scholar
• Tvede N., Pedersen B K., Hansen F R., Bendix T., Christensen L D., Galbo H., Halkjaer-Kristensen J. Effect of physical exercise on blood mononuclear cell subpopulations and in vitro proliferative responses. Scand. J. Immunol 1989; 29: 383–389
   PubMed Web of Science ®Google Scholar
• Morgan E L., McClurg M R., Janda J A. Suppression of human B lymphocyte activation by β-endorphin. Journal of Neuroimmunology 1990; 28: 209–217
   PubMedGoogle Scholar
• Johnson H M., Smith E M., Torres B A., Blalock J E. Regulation of the in vitro antibody response by neuroendo-crine hormones. Proceedings of the National Academy of Sciences of USA. 1982. 79: 4171–4174
   Google Scholar
• Munn N A., Lum L G. Immunoregulatory Effects of α-Endorphin, β-Endorphin, Methionine-Enkephalin, and Adrenocorticotropic Hormone on Anti-tetanus Toxoid Antibody Synthesis by Human Lymphocytes. Clinical Immunology and Immunopathology 1989; 52: 376–385
   Google Scholar
• Kusnecov A W., Husband A J., King M G., Smith R. Modulation of Mitogen-Induced Spleen Cell Proliferation and the Antibody-Forming Cell Response by β-Endorphin in vivo. Peptides 1989; 10: 473–479
   Google Scholar
• van den Bergh P., Rozing J., Nagelkerken L. Beta-endorphin Stimulates la Expression on Mouse B Cells by Inducing Interleukin-4 Secretion by CD4 + T cells. Cellular Immunology 1993; 149: 180–192
   Google Scholar
• Taube D P., Eisenstein T K., Geller E B., Adler M W., Rogers T J. Immunomodulatory activity of μ.-and K-selective opioid agonists. Proc. Natl Acad. Sci. USA 1991; 88: 360–364
   Google Scholar
• Carr D J.J., Radulescu R T., de Costa B R., Rice K C., Blalock J E. Differential effects of opioids on immunoglob-ulin production by lymphocytes isolated from Peyer's Patches and spleen. Life Sciences 1990; 47: 1059–1069
   PubMedGoogle Scholar
• Mathews P M., Froehlich C J., Sibbit W L., Bankhurst A D. Enhancement of natural cytotoxicity by β-endorphin. The Journal of Immunology 1983; 130: 1658–1662
   PubMed Web of Science ®Google Scholar
• Kay N, Allen J., Morley J E. Endorphins stimulate normal human peripheral blood lymphocyte natural killer activity. Life Sciences 1984; 35: 53–59
   PubMed Web of Science ®Google Scholar
• Puente J., Maturana P., Miranda D., Navarro C, Wolf M E., Mosnaim A D. Enhancement of Human Natural Killer Cell Activity by Opioid Peptides: Similar Response to Methionene-Enkephalin and β-Endorphin. Brain, Behavior, and Immunity 1992; 6: 32–39
   PubMed Web of Science ®Google Scholar
• Yeager M P., Yu C T., Campbell A S., Moschella M., Guyre P M. Effect of Morphine and β-Endorphin on Human Fc Receptor-Dependent and Natural Killer Cell Functions. Clinical Immunology and Immunopathology 1992; 62: 336–343
   PubMedGoogle Scholar
• Chiapelli F., Yamashita N., Kemeny M., Bullington R., Nguyen L., Clement L T., Fahey J L. Differential effect of beta-endorphin on three human cytotoxic cell populations. International Journal of Immunopharmacology 1991; 13: 291–297
   Google Scholar
• Shavit Y., Lewis J W., Terman G W. Opioid Peptides Mediate the Suppressive Effect of Stress on natural Killer Cell Cytotoxicity. Science 1984; 223: 188–190
   PubMed Web of Science ®Google Scholar
• Kraut R P., Greenberg A H. Effects of Endogenous and Exogenous Opioids on Splenic Natural Killer Cell Activity. Natural Immunity and Cell Growth Regulation 1986; 5: 28–40
   PubMedGoogle Scholar
• Mozzanica N., Finzi A F., Foppa S., Vignati G., Villa M L. Association between circadian rhythms of endogenous hypothalamic opioid peptides and of natural killer cell activity. International Journal of Immunopharmacology 1991; 13: 317–321
   PubMed Web of Science ®Google Scholar
• Mandler R N., Biddison W E., Mandler R., Serrate S A. β-endorphin augments the cytolytic activity and interferon production of natural killer cells. The Journal of Immunology 1986; 136: 934–939
   PubMed Web of Science ®Google Scholar
• Brown S L., van Epps D E. Opioid Peptides Modulate Production of Interferon γ by Human Mononuclear Cells. Cellular Immunology 1986; 103: 19–26
   PubMedGoogle Scholar
• Froehlich C J., Bankhurst A D. The effect of β-endorphin on natural killer cytotoxicity and antibody dependent cellular cytotoxicity. Life Sciences 1984; 35: 261–265
   Google Scholar
• Sharp B M., Keane W F., Suh H J., Gekker G., Tsukayama D., Peterson P K. Opioid peptides rapidly stimulate superoxide production by human polymorphonuclear leukocytes and macrophages. Endocrinology 1985; 117: 793–795
   PubMed Web of Science ®Google Scholar
• Sharp B M., Tsukayama D T., Gekker G., Keane W F., Peterson P K. β-Endorphin Stimulates Human Polymorphonuclear Leukocyte Superoxide Produciton via a Stereo-selective Opiate Receptor. The Journal of Pharmacology and Experimental Therapeutics 1987; 242: 579–582
   Google Scholar
• Peterson P K., Sharp B., Gekker G., Brummitt C., Keane W F. Opioid-mediated suppression of cultured peripheral blood mononuclear cell respiratory burst activity. The Journal of Immunology 1987; 138: 3907–3912
   Google Scholar
• van Epps D E., Saland L. β-endorphin and met-enkephalin stimulate human peripheral blood mononuclear cell chemo-taxis. The Journal of Immunology 1984; 132: 3046–3053
   PubMed Web of Science ®Google Scholar
• van Epps D E., Kutvirt S L. Modulation of human ncutrophil adherence by β-endorphin and met-enkephalin. Journal of Neuroimmunology 1987; 15: 219–228
   PubMed Web of Science ®Google Scholar
• Sacerdote P., Panerai A E. Analysis of the Beta-Endorphin Structure-Related Activity on Human Monocyte Chemotaxis: Importance of the N-and C-Terminal. Peptides 1989; 10: 565–569
   Google Scholar
• Smith E M., Galin F S., LeBoeuf R D., Coppenhaver D H., Harbour D V., Blalock J E. Nucleotide and amino acid sequence of lymphocyte-derived corticortropin: Endotoxin induction of a truncated peptide. Proceedings of the National Academy of Sciences USA 1990; 87, 1057–1060
   Google Scholar
• Lolait S J., Clements J A., Markwick A J., Cheng C, Mc-Nally M., Smith A I., Funder J W. Pro-opiome-lanocortin Messenger Ribonucleic Acid and Posttransla-tional Processing of Beta Endorphin in Spleen Macrophages. Journal of Clinical Investigations 1986; 77: 1776–1779
   PubMed Web of Science ®Google Scholar
• Kavelaars A., Ballieux R E., Heijnen C J. The role of IL-1 in the corticotropin-releasing factor and arginine-vasoprcssin-indused secretion of immunoreactive β-endorphin by human peripheral blood mononuclear cells. The Journal of Immunology 1989; 142: 2338–42
   PubMed Web of Science ®Google Scholar
• Lolait S J., Lim A T., Toh B H., Funder J W. Immunoreactive beta-endorphin in a subpopulation of mouse spleen macrophages. Journal of Clinical Investigations 1984; 73: 277–280
   PubMed Web of Science ®Google Scholar
• Kavelaars A., Berkenbosch F., Croiset G., Ballieux R E., Heijnen C J. Induction of β-Endorphin Secretion by Lymphocytes after Subcutaneous Administration of Corticotropin-Releasing Factor. Endocrinology 1990; 126: 759–764
   PubMedGoogle Scholar
• Kavelaars A., Ballieux R E., Heijnen C J. Two Different Signaling Pathways for the Induction of Immunoreactive β-Endorphin Secretion by Human Peripheral Blood Mononuclear Cells. Endocrinology 1991; 128: 765–770
   Google Scholar
• Weigent D A., Blalock J E. Interactions between the Neuroendocrine and Immune Systems: Common Hormones and Receptors. Immunologkal Reviews 1987; 100: 79–108
   PubMed Web of Science ®Google Scholar
• Kavelaars A., Ballieux R E., Heijnen C J. In vitro β-Adrenergic Stimulation of Lymphocytes Induces the Release of Immunoreactive P-Endorphin. Endocrinology 1990; 126: 3028–3032
   Google Scholar
• Carr D J.J., DeCosta B R., Jacobsen A E., Rice K C., Blalock J E. Corticotropin-releasing hormone augements natural killer cell activity through a naloxone-sensitive pathway. Journal of Neuroimmunology 1990; 28: 53–61
   PubMed Web of Science ®Google Scholar
• Stein G, Gramsch C., Herz A. Intrinsic Mechanisms of Antinociception in Inflammation: Local Opioid Receptors and β-Endorphin. The Journal of Neuroscience 1990; 10: 1292–1298
   PubMed Web of Science ®Google Scholar
• van Woudenberg A D., Metzelaar M J., van der Kleij A A., De Wied D., Burbach J P., Wiegant V M. Analysis of Proopiomelanocortin (POMC) Messengee Ribonucleic Acid and POMC-derived Peptides in Human Peripheral Blood Mononuclear Cells: No Evidence for a Lymphocyte-derived POMC System. Endocrinology 1993; 133: 1922–1933
   Google Scholar
• Parsadaniantz S M., Lenoir V., Ferlain B., Kerdelhué B. Lack of Effect of Interleukins 1 α and 1β, During In Vitro Perfusion, on Anterior Pituitary Release of Adrenocorti-cotropic Hormone and β-endorphin in the Male Rat. Journal of Neuroscience Research 1993; 34: 315–323
   Google Scholar
• Fagarasan M O., Arora P K., Axelrod J. Interleukin-1 potentiation of β-end orphin secretion and the dynamics of interleukin-1 internalization in pituitary cells. Progress in Neuro-Psychopharmacology & Biological Psychiatry 1991; 15: 551–560
   PubMed Web of Science ®Google Scholar
• Lissoni P., Barni S., Rovelli F., Crispino S., Fumagalli G., Pescia S., Vaghi M., Camesasca G., Tancini G. Neuroendocrine effects of subcutaneous interleukin-2 injection in cancer patients. Tumori 1991; 77: 212–215
   Google Scholar
• Fagarasan M O., Axelrod J., Catt K J. Interleukin-1 potentiates agonist-induced secretion of β-endorphin in anterior pituitary cells. Biochemical and Biophysical Research Communications 1990; 173: 988–993
   Google Scholar
• Greenberg J., Ellyin F., Pullen G., Ehrenpreis S., Singh A P., Cheng J. Methionine-enkephalin and β-endorphin levels in brain, pancreas, and adrenals of db/db mice. Endocrinology 1985; 116: 328–331
   Google Scholar
• Timmers K., Voyles N R., Zalenski C, Wilkins S., Recant L. Altered β-endorphin, Met and Leu-enkephalins, and enkephalin-containing peptides in pancrease and pituitary of genetically obese diabetic (db/db) mice during development of diabetic syndrome. Diabetes 1986; 35: 1143–1151
   PubMed Web of Science ®Google Scholar
• Awoke S., Voyles N R., Bathena S J., Tanenberg R J., Recant L. Alterations of plasma opioid activity in human diabetics. Life Sci 1984; 34: 1999–2006
   PubMed Web of Science ®Google Scholar
• Vermes I., Steinmetz E., Schoorl J., van der Veen E A., Tilders F J.H. Increased plasma levels of immunoreactive β-endorphin and corticotropin in non-insulin-dependent diabetes (Letter). Lancet 1985; 11: 725–726
   Google Scholar
• Burrin J M., Yeo T H., Kohner E M., Jone J. Plasma immunoreactive β-endorphin in non-insulin dependent diabetes (Letter). Lancet 1986; 1: 855
   Google Scholar
• Solerte S B., Petraglia F., Facchinetti F., Genazzani A R., Ferrari E. Dissociation between β-lipoprotein and ACTH secretion in type-1 and type-2 diabetes mellitus. J. Endocrinol. Invest. 1985; 8: 197
   Google Scholar
• Giugliano D., Torella R., Lefebvre P J., D'Onofrio F. Opioid pepetides and metabolic regulation. Review: Diabe-tologia 1988; 31: 3–14
   PubMedGoogle Scholar
• Reid R L., Sandier J A., Yen S S.C. Beta-endorphin stimulates the secretion of insulin and glucagon in diabetes mellitus. Metabolism 1984; 33: 197–199
   Google Scholar
• Giugliano D., Ceriello A., Salvatore T., Paolisso G., D'Onofrio F., Lefebvre P J. β-endorphin infusion restores acute insulin responses to glucose in type-2 diabetes mellitus. J. Clin. Endocrinol. Metab 1987; 64: 944–948
   PubMedGoogle Scholar
• Lerner A B., Nordlund J J. Vitiligo: What is it? Is it important?. JAMA 1979; 293: 1183–1187
   Google Scholar
• Mozzanica N., Villa M L., Foppa S., Vignati G., Cattaneo A., Diotti R., Finzi A F. Plasma α-melanocyte-stimulating hormone, β-endorphin, met-enkephalin, and natural killer cell activity in vitiligo. J. Am. Acad. Dermatol 1992; 26: 693–700
   PubMedGoogle Scholar
• Weigert A D., Blalock E J. Interactions between the neuroendocrine and immune responses: Common hormones and receptors. Immunol. Rev 1989; 100: 79–108
   Google Scholar
• Nakamura H., Yoshino S. Opioid peptides in RA. J. Rheu-matol, 1990: 17980–981
   Google Scholar
• Levine D J., Clark R., Devor M., Helms C, Moskowitz A M., Basbaum I A. Intraneuronal substance P contributes to the severity of experimental arthritis. Science 1984; 226: 547–549
   PubMed Web of Science ®Google Scholar
• Lotz M., Carson A D., Vaughan H J. Substance P activation of rheumatoid synovitis. Neural pathway in pathogen-esis of arthritis. Science 1987; 235: 893–895
   PubMed Web of Science ®Google Scholar
• Yoshino S., Koiwa M, Shiga H., Nakamura H. Detection of opioid peptides in synovial tissue of patients with rheumatoid arthritis. J. Rheumalol 1992; 19: 660–668
   Google Scholar
• Denko C W., Aponte J., Gabriel P., Petricevik M. Beta-endorphin, immunological and biochemical changes in synovial fluid in rheumatic disorders. Clin. Rheumatol 1986; 5: 25–32
   Google Scholar
• Yunus M B., Denko C W., Masi A T. Serum β-endorphin in primary fibromyalgia syndrome: A controlled study. J. Rheumalol 1986; 13: 183–186
   PubMed Web of Science ®Google Scholar
• Epstein F H. Rheumatoid arthritis. Pathophysiology and implications for therapy. New Engl. J. Med 1990; 322: 1277–1289
   Google Scholar
• Abruzzo L V., Rowley D A. Homeostasis of the antibody response: Immunoregulation by NK cells. Science 1983; 222: 581–585
   PubMed Web of Science ®Google Scholar